Page 7 - Hannover Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genetic Defect Disrupts Blood Formation & Immune System, Study Finds

Genetic Defect Disrupts Blood Formation & Immune System, Study Finds
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSamaneh zoghiRocio cabrera perezAngela deya martinezSevgi kostel balChristina rashkovaAlexander hoischenIrinka castanonRyohei kondoSabine illsingerKerstin kutscheHang brunnerWinfriedf picklMitsuhiro fujiwara

AstraZeneca in deal with start-up to fight diabetes

The FTSE 100 firm will team up with London-based Quell Therapeutics to collaborate on research and the licensing of any new medicines.

City ofUnited kingdomMartin murphyIain mcgillIskra reicKing college londonDrug administrationUniversity college londonHannover medical schoolLondon based quell therapeuticsCollege londonHannover medical

AstraZeneca in deal with start-up to fight diabetes

The FTSE 100 firm will team up with London-based Quell Therapeutics to collaborate on research and the licensing of any new medicines.

United kingdomCity ofIskra reicIain mcgillMartin murphyUniversity college londonDrug administrationKing college londonHannover medical schoolLondon based quell therapeuticsCollege londonHannover medical

Gilead Sciences (GILD) Reports Positive CHMP Opinion for Hepcludex

Gilead Sciences (GILD) Reports Positive CHMP Opinion for Hepcludex
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Foster cityUnited statesHeiner wedemeyerMeaghan smithFrank duffJacquie rossGilead sciences in liver diseaseGilead on twitter sciencesExchange commissionGilead sciences incCommittee for medicinal products human useDrug administrationGilead sciencesEuropean medicines agencyEuropean unionGilead public affairs

CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)

If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU . | May 4, 2023

Foster cityUnited statesFrank duffHeiner wedemeyerGilead sciencesGilead sciences incEuropean medicines agencyHannover medical schoolDrug administrationCommittee for medicinal products human useExchange commissionEuropean unionGilead sciences in liver diseaseEuropean commissionMedicinal productsHuman use